Researcher
Veerle SOMERS
- Keywords:Biomedical sciences (incl. biochemistry)
- Disciplines:Autoimmunity, General diagnostics, Adaptive immunology, Musculo-skeletal systems, Developmental neuroscience
Affiliations
- Immunology & Infection (Department)
Member
From1 Jan 2020 → Today - Immunology & Infection (Research group)
Member
From1 Jan 2020 → Today - Biomedical Research Institute (Research institute)
Member
From11 Dec 2003 → Today - Faculty of Medicine and Life Sciences (Faculty)
Member
From16 Jan 2003 → Today - Immunology - Biochemistry (Research group)
Member
From11 Dec 2003 → 31 Dec 2019 - Physiology - Biochemistry - Immunology (Department)
Member
From1 Oct 2003 → 31 Dec 2019 - Medical Basic Sciences (Division)
Member
From16 Jan 2003 → 30 Sep 2009
Projects
1 - 10 of 48
- Francqui Chair prof. dr. SwinnenFrom1 Oct 2023 → TodayFunding: Foundations, funds and other with scientific goal
- Novel antibody biomarkers for the prediction of response to first-line therapy in rheumatoid arthritisFrom15 Jan 2023 → 14 Jan 2024Funding: IOF - technology concept exploration
- Spinal cord injury induced autoantibodies as biomarkers for patient stratificationFrom1 Nov 2022 → TodayFunding: FWO Strategic Basic Research Grant
- Anti-UH-RA antibody reactivity for prediction of response to first-line therapy in rheumatoid arthritis: validation in the independent CAP48 cohort.From1 Oct 2022 → 1 Dec 2023Funding: Foundations, funds and other with scientific goal
- Deep immune-phenotyping of multiple sclerosis patients using advanced spectral flow cytometryFrom1 Jan 2022 → 31 Dec 2023Funding: Foundations, funds and other with scientific goal
- The MIF-CD74 system as a driver of pro-inflammatory B cell responses following traumatic spinal cord injury (SCI).From1 Oct 2021 → TodayFunding: BOF - doctoral mandates
- Elucidating the role of double homeobox protein 4 (DUX4) in the pathology of inflammatory arthritisFrom1 Jan 2021 → 31 Dec 2021Funding: Foundations, funds and other with scientific goal
- Understanding how B cell depletion with ocrelizumab affects the immune system in the treatment of MSFrom1 Jan 2021 → 30 Jun 2023Funding: Foundations, funds and other with scientific goal
- Spinal cord injury induced autoantibodies as biomarkers for patient stratificationFrom1 Nov 2020 → 31 Oct 2022Funding: FWO Strategic Basic Research Grant
- Protective versus damaging aspects of the immune reaction in relation to clinical outcome in the Limburg COVID-19 cohortFrom15 Jun 2020 → 14 Jun 2022Funding: BOF - projects
Publications
21 - 30 of 127
- Circulating immune profile changes reflect memory immune responses in spinal cord injury patients(2021)
Authors: Judith FRAUSSEN, Lien BECKERS, Charlotte C. Van Laake Geelen, Bart Depreitere, Jens Deckers, Dieter Peuskens, Veerle SOMERS
Pages: 106 - SCREENING FOR IMMUNOGLOBULIN A ANTIBODY REACTIVITY IN EARLY AXIAL SPONDYLOARTHRITIS IDENTIFIES NOVEL ANTIGENIC TARGETS(2020)
Authors: Patrick VANDORMAEL, Dana QUADEN, Pieter RUYTINX, Jaak JANSSENS, Johan VANHOOF, Piet GEUSENS, Veerle SOMERS
Pages: 1916 - 1916 - Immune regulation by dimethyl fumarate (DMF) in relapsing- remitting multiple sclerosis patients(2020)
Authors: Gwendoline MONTES DIAZ, Veerle SOMERS
Number of pages: 209 - Microglial derived extracellular vesicles activate autophagy and mediate multi‐target signaling to maintain cellular homeostasis(2020)
Authors: Bram VAN DEN BROEK, Isabel Pintelon, Ibrahim HAMAD, Sofie KESSELS, Mansour HAIDAR, Niels HELLINGS, Jerome HENDRIKS, Markus KLEINEWIETFELD, Bert BRONE, Vincent Timmerman, et al.
- Antibodies against three novel peptides in early axial spondyloarthritis patients from two independent cohorts(2020)
Authors: Dana QUADEN, Patrick VANDORMAEL, Pieter RUYTINX, Piet GEUSENS, Kristoff CORTEN, Johan VANHOOF, Jori LIESENBORGS, Frank VAN REETH, Anouk AGTEN, Frank VANDENABEELE, et al.
Pages: 2094 - 2105 - NOVEL AUTOANTIBODY BIOMARKERS FOR THE PREDICTION OF THERAPY RESPONSE IN RHEUMATOID ARTHRITIS(2020)
Authors: Patrick VANDORMAEL, Astrid PUES, Ellen SLEURS, P. Verschueren, Veerle SOMERS
Pages: 900 - 900 - SEROCONVERSION OF AUTOANTIBODIES TO UH-RA.21 PEPTIDE IS ASSOCIATED WITH CDAI REMISSION IN RHEUMATOID ARTHRITIS PATIENTS OF THE CARERA COHORT(2019)
Authors: Silke LOYENS, Patrick VANDORMAEL, Liesbeth DE WINTER, Veerle Stouten, Piet GEUSENS, Patrick Verschueren, Veerle SOMERS
Pages: 1435 - 1436 - Methylglyoxal-Derived Advanced Glycation Endproducts Accumulate in Multiple Sclerosis Lesions(2019)
Authors: Suzan WETZELS, Tim VANMIERLO, Jean L. J. M. Scheijen, Jack VAN HORSSEN, Sandra Amor, Veerle SOMERS, Casper G. Schalkwijk, Jerome HENDRIKS, Kristiaan WOUTERS
- AUTOANTIBODIES TO THREE NOVEL PEPTIDES IN EARLY AXIAL SPONDYLOARTHRITIS IN TWO INDEPENDENT COHORTS(2019)
Authors: Dana QUADEN, Patrick VANDORMAEL, Piet GEUSENS, Johan VANHOOF, Kurt de Vlam, Veerle SOMERS
Pages: 863 - 864 - IgD(-)CD27(-) double negative B cells of multiple sclerosis patients have a pro-inflammatory migratory phenotype and function(2019)
Authors: Lien BECKERS, G. Montes Diaz, L. M. Villar, Bart VAN WIJMEERSCH, Veerle SOMERS, Judith FRAUSSEN
Pages: 442 - 443
Patents
1 - 9 of 9
- Method and means for diagnosis of spondyloarthritis (Inventor)
- Biomarkers for rheumatoid arthritis (Inventor)
- MEANS AND METHODS FOR THE DETERMINATION OF THE JOINT DESTRUCTION PROGRESSION RATE IN RHEUMATOID ARTHRITIS PATIENTS (Inventor)
- BIOMARKERS FOR MULTIPLE SCLEROSIS (Inventor)
- CITRULLINATION SPECIFIC PHAGE DISPLAY (Inventor)
- Biomarkers for rheumatoid arthritis (Inventor)
- CITRULLINATION SPECIFIC PHAGE DISPLAY (Inventor)
- Biomarkers for rheumatoid arthritis (Inventor)
- BIOMARKERS FOR RHEUMATOID ARTHRITIS (Inventor)
Linked dataset
1 - 1 of 1